There were 11 hypersensitivity reactions, all in patients receiving nivolumab. Reducing the infusion time for nivolumab and pembrolizumab to 10 minutes is feasible and safe, according to researchers.
Please provide your email address to receive an email when new articles are posted on . Infusion-related reactions occurred at similar rates for 30-minute and 10-minute pembrolizumab infusions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results